A sharp decline in sales at x-ray film digitizer firm Howtek hasforced the Hudson, NH, company to cut 20 jobs. Howtek attributedthe revenue shortfall to delays in getting Food and Drug Administrationclearance for its Scanmaster DX product. The FDA
A sharp decline in sales at x-ray film digitizer firm Howtek hasforced the Hudson, NH, company to cut 20 jobs. Howtek attributedthe revenue shortfall to delays in getting Food and Drug Administrationclearance for its Scanmaster DX product. The FDA cleared the digitizerin January, three months after Howtek's planned launch date inNovember.
For the first quarter of 1996 (end-March), Howtek had salesof $2 million, a major drop from the $5.9 million in revenuesposted in the first quarter of 1995. The company registered aloss of $2.3 million, compared with net income of $153,000 inthe same quarter a year ago.
Howtek said that weakness in the graphic arts market, whereit also markets its scanners, also contributed to the shortfall.The company said that the layoffs are designed to get expensesback in line with revenues.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.